Research Article
Prevalence of Sarcopenic Obesity in Adults with Class II/III Obesity Using Different Diagnostic Criteria
Table 4
Prevalence of sarcopenic obesity in the study cohort () using various sex-specific definitions determined by anthropometric and dual-energy X-ray absorptiometry measurements amongst studies investigating sarcopenic obesity.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Terminology for variables is selected for consistency and may differ from terms used by original authors. bWhere applicable, equivalent cut points derived from the study-specific cohort are listed in the text. cCut points determined from reported sex-specific mean and standard deviation in Oh et al., 2015[32]. dHA-LM: high adiposity (FMI 50–100) and low muscle mass (ASMI 0–49.99) with individual z-scores based upon age, sex, and BMI. LSTI: lean soft tissue index; NA: not applicable; LST: lean soft tissue; ASM: appendicular skeletal muscle mass; BMI: body mass index; ASMI: appendicular skeletal mass index; FMI: fat mass index; FM: fat mass; FFM: fat-free mass. |